Bibliographic record
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K. New England Journal of Medicine 2021
§1Bibliographic record
§1.1Record
- Authors
- Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K
- Title
- Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
- Source
- New England Journal of Medicine
- Year
- 2021
- Volume, issue, pages
- 385(6):503–515
- Digital object identifier
- 10.1056/NEJMoa2107519
- PubMed identifier
- 34170647
- Record type
- Journal article
- Institute identifier
- CEI-BR-027
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Tirzepatide | Compound monograph |
| Trial abstract: SURPASS-2 | Trial abstract |
| Synthesis: Tirzepatide compared with semaglutide in type 2 diabetes | Evidence synthesis |
| 3 citing documents. | |
§1.3Subject tags
tirzepatide semaglutide head-to-head SURPASS
Compound Evidence Institute · CEI-BR-027 · https://compoundevidence.com/bibliography/frias2021/ · retrieved 30 July 2026